MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer von Schultz, Nicolai A, Dehlendorff, Christian, Jensen, Benny V, Bjerregaard, Jon K, Nielsen, Kaspar R, Bojesen, Stig E, Calatayud, Dan, Nielsen, Svend E, Yilmaz, Mette, Holländer, Niels Henrik, Andersen, Klaus K, Johansen, Julia S

Volltext

Characteristics, therapy and outcome in an unselected and prospectively registered cohort of pancreatic cancer patients von Bjerregaard, J.K, Mortensen, M.B, Schønnemann, K.R, Pfeiffer, P

Volltext

Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer von Brännström, Fredrik, Bjerregaard, Jon K, Winbladh, Anders, Nilbert, Mef, Revhaug, Arthur, Wagenius, Gunnar, Mörner, Malin

Volltext

Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer von Schultz, Nicolai A, Christensen, Ib J, Werner, Jens, Giese, Nathalia, Jensen, Benny V, Larsen, Ole, Bjerregaard, Jon K, Pfeiffer, Per, Calatayud, Dan, Nielsen, Svend E, Yilmaz, Mette K, Holländer, Niels H, Wøjdemann, Morten, Bojesen, Stig E, Nielsen, Kaspar R, Johansen, Julia S

Volltext

The Impact of Exacerbation Frequency on Clinical and Economic Outcomes in Swedish COPD Patients: The ARCTIC Study von Larsson, Kjell, Janson, Christer, Lisspers, Karin, Ställberg, Björn, Johansson, Gunnar, Gutzwiller, Florian S, Mezzi, Karen, Bjerregaard, Bine Kjoeller, Jorgensen, Leif

Volltext

Prognostic Factors for Survival and Resection in Patients With Initial Nonresectable Locally Advanced Pancreatic Cancer Treated With Chemoradiotherapy von Bjerregaard, Jon K., M.D, Mortensen, Michael B., M.D., Ph.D, Jensen, Helle A., M.D, Nielsen, Morten, M.Sci., Ph.D, Pfeiffer, Per, M.D., Ph.D

Volltext

2309 Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS2w) administered every second week in patients with advanced gastro-esophageal cancer von Schoennemann, K.R, Vestermark, L.W, Jensen A, H, Bjerregaard K, J, Krogh, M, Qvortrup, C, Tarpgaard S, L, Ejlsmark, M.W, Pfeiffer, P

Volltext

A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma von Petersen, Peter C., Petersen, Lone N., Vogelius, Ivan, Bjerregaard, Jon K., Baeksgaard, Lene

Volltext

Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer von Chen, Inna M, Johansen, Astrid Z, Dehlendorff, Christian, Jensen, Benny V, Bojesen, Stig E, Pfeiffer, Per, Bjerregaard, Jon K, Nielsen, Svend Erik, Andersen, Fahimeh, Holländer, Niels H, Yilmaz, Mette K, Rasmussen, Louise S, Johansen, Julia S

Volltext

Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer von Rasmussen, Louise S., Yilmaz, Mette K., Falkmer, Ursula G., Poulsen, Laurids Ø., Bøgsted, Martin, Christensen, Heidi S., Bojesen, Stig E., Jensen, Benny V., Chen, Inna M., Johansen, Astrid Z., Hansen, Carsten P., Hasselby, Jane P., Holländer, Niels, Nielsen, Svend E., Andersen, Fahimeh, Bjerregaard, Jon K., Pfeiffer, Per, Johansen, Julia S.

Volltext

Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum von Schoennemann, Katrine R., Bjerregaard, Jon K., Hansen, Tine P., De Stricker, Karin, Gjerstorff, Morten F., Jensen, Helle A., Vestermark, Lene W., Pfeiffer, Per

Volltext

Prognostic impact of Charlson’s Age‐Comorbidity Index and other risk factors in patients with pancreatic cancer von Bagni, Karin, Chen, Inna M., Johansen, Astrid Z., Dehlendorff, Christian, Jensen, Benny V., Hansen, Carsten P., Preus Hasselby, Jane, Holländer, Niels H., Nissen, Mette, Bjerregaard, Jon K., Pfeiffer, Per, Yilmaz, Mette K., Rasmussen, Louise S., Nielsen, Svend E., Johansen, Julia S.

Volltext

Response to the letter entitled: Re: Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancr... von Rasmussen, Louise S., Yilmaz, Mette K., Falkmer, Ursula G., Poulsen, Laurids Ø., Bøgsted, Martin, Christensen, Heidi S., Bojesen, Stig E., Jensen, Benny V., Chen, Inna M., Johansen, Astrid Z., Hansen, Carsten P., Hasselby, Jane P., Holländer, Niels, Nielsen, Svend E., Andersen, Fahimeh, Bjerregaard, Jon K., Pfeiffer, Per, Johansen, Julia S.

Volltext

Phase II study of biweekly cetuximab in combination with irinotecan as second-line treatment in patients with platinum-resistant gastro-oesophageal cancer von Schønnemann, K.R, Yilmaz, M, Bjerregaard, J.K, Nielsen, K.M, Pfeiffer, P

Volltext

Clinical utility of plasma cell-free DNA in patients with pancreatic cancer von Chen, I., Wind, K.L., Dehlendorff, C., Sørensen, B.S., Vittrup, B.V., Johansen, A., Pfeiffer, P., Bjerregaard, J.K., Bojesen, S.E., Nielsen, S.E., Holländer, N.H., Yilmaz, M.K., Rasmussen, L.S., Pallisgaard, N., Johansen, J.S., Spindler, K.-L.G.

Volltext

Clinical utility of serum type III collagen in patients with pancreatic carcinoma von Chen, I., Willumsen, N., Dehlendorff, C., Johansen, A., Vittrup, B.V., Krüger, M., Pfeiffer, P., Bjerregaard, J.K., Bojesen, S.E., Nielsen, S.E., Holländer, N.H., Yilmaz, M.K., Rasmussen, L.S., Karsdal, M., Johansen, J.S.

Volltext

S-1 in combination with docetaxel and oxaliplatin in patients with advanced gastro-esophageal adenocarcinoma: two parallel phase 1/2a studies von Pfeiffer, Per, Qvortrup, Camilla, Krogh, Merete, Schoennemann, Katrine, Vestermark, Lene W, Jensen, Helle A, Bjerregaard, Jon K

Volltext

Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients von Pfeiffer, Per, Qvortrup, Camilla, Bjerregaard, Jon K

Volltext

Characteristics, therapy and outcome in an unselected and prospectively registered cohort of patients with gastro-oesophageal cancer von Schønnemann, Katrine R., Mortensen, Michael B., Bjerregaard, Jon K., Fristrup, Claus, Pfeiffer, Per

Volltext

In Reply to Parlak and Topkan von Bjerregaard, Jon K., MD, Jensen, Helle A., MD, Nielsen, Morten, PhD, Msci, Pfeiffer, Per, MD, PhD, Mortensen, Michael B., MD, PhD

Volltext